Contineum Therapeutics, Inc.
CTNM
$4.62
$0.245.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 63.56% | 58.31% | -- | 149.60% | 165.01% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.29% | -48.75% | -- | -- | 118.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 61.61% | 56.43% | -- | -- | 163.90% |
|
|
|||||
| Total Current Assets | 61.61% | 56.43% | -- | -- | 163.90% |
| Net Property, Plant & Equipment | 362.13% | -34.75% | -- | -- | -33.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -99.77% | -98.06% | -- | -- | 894.57% |
| Total Assets | 63.24% | 55.37% | -- | -- | 157.50% |
|
|
|||||
| Total Accounts Payable | 185.20% | 32.54% | -- | -- | 47.67% |
| Total Accrued Expenses | 53.04% | -17.16% | -- | -- | 112.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 212.93% | -45.50% | -- | -- | -90.83% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 81.87% | -21.92% | -- | -- | -27.36% |
|
|
|||||
| Total Current Liabilities | 81.87% | -21.92% | -- | -- | -27.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4,350.93% | -- | -- | -- | -86.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -96.36% |
| Total Liabilities | 159.22% | -23.29% | -- | -- | -49.83% |
|
|
|||||
| Common Stock & APIC | 4,342.21% | 4,844.68% | -- | -- | 50.17% |
| Retained Earnings | -56.24% | -52.63% | -- | -- | 23.22% |
| Treasury Stock & Other | -34.26% | 730.34% | -- | -- | 242.11% |
| Total Common Equity | 391.55% | 443.82% | -- | 18.86% | 27.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 45.39% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 45.39% | 45.39% |
|
|
|||||
| Total Common Equity | 391.55% | 443.82% | -- | 18.86% | 27.12% |
| Total Preferred Equity | -- | -- | -- | 45.39% | 45.39% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 58.85% | 59.90% | -- | 197.91% | 217.50% |
|
|
|||||